Ocumetics Technology Corp is pioneering bio lens technology with its innovative intraocular lens, which allows for seamless focus shifting between distant and close-range objects, and is poised to expand its reach beyond Canada.

Ocumetics Technology Corp’s stock price has surged following the successful implantation of its bionic lens, marking a significant milestone in the company’s product development journey.

Ocumetics Technology Corp has successfully implanted its innovative intraocular lens in human patients, marking a significant milestone in the field of ophthalmic technology and potentially revolutionizing vision correction.

Ocumetics Technology Corp. is set to begin its first-in-human clinical study on June 26, 2025, marking a major milestone in the development of its innovative intraocular lens technology.